Volume 22, Number 6—June 2016
Research
Human Adenovirus Associated with Severe Respiratory Infection, Oregon, USA, 2013–2014
Table 2
Characteristic | HAdV-B7, no. (%) | Non–HAdV-B7, no. (%)† | p value |
---|---|---|---|
Total |
64 |
45 |
|
Age group, y | |||
Children, <18 | 28 (43.7) | 36 (80.0) | <0.001 |
Adults, >18 |
36 (56.3) |
9 (20.0) |
|
Illness severity | |||
Hospitalized | 54 (84.4) | 31 (68.9) | <0.05‡ |
Admitted to ICU§ | 25 (46.3) | 8 (25.8) | 0.06 |
Required mechanical ventilation§ |
13 (24.1) |
4 (12.9) |
0.26 |
Days hospitalized¶ | |||
< Median, 4 | 14 (35.0) | 19 (70.4) | <0.05 |
> Median, 4 | 26 (65.0) | 8 (29.6) |
*HAdV, human adenovirus; ICU, intensive care unit
†Includes only the 109 specimens that were typed. Non-HAdV-B7: HAdVs-B3, -B21, HAdVs-C1, -C2, -C5, and HAdV-E4.
‡Not significant after adjustment for age.
§Among hospitalized case-patients.
¶A total of 40 HAdV-B7 case-patients and 27 non–HAdV-B7 case-patients had both hospital admission and discharge dates.
Page created: May 16, 2016
Page updated: May 16, 2016
Page reviewed: May 16, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.